VF
PTCT icon

Virtu Financial’s PTC Therapeutics PTCT Stock Holding History

Virtu Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,222
Closed -$254K – 1958
2023
Q4 		$254K Sell
9,222
-2,689
-23% -$61.5K 0.02% 686
2023
Q3 		$267K Buy
+11,911
New +$443K 0.03% 553
2022
Q3 		– Sell
-6,589
Closed -$264K – 2136
2022
Q2 		$264K Buy
+6,589
New +$231K 0.02% 640
2021
Q1 		– Sell
-8,358
Closed -$510K – 1930
2020
Q4 		$510K Buy
+8,358
New +$493K 0.06% 434
2018
Q2 		– Sell
-8,943
Closed -$242K – 2391
2018
Q1 		$242K Sell
8,943
-5,861
-40% -$149K 0.01% 1217
2017
Q4 		$247K Buy
+14,804
New +$251K 0.01% 1447

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's PTCT Position: Q1 2024 in Review

Virtu Financial sold out of PTC Therapeutics (PTCT) in Q1 2024, closing a stake of 9,222 shares — an estimated $254K sold.

Virtu Financial first reported a position in PTCT in Q4 2017 and held it in 6 quarters. The position peaked at $510K in Q4 2020. 183 funds tracked by Wall St. Rank hold PTCT as of Q1 2024.

  • Virtu Financial reported no remaining PTC Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 9,222 PTC Therapeutics shares in Q1 2024, an estimated $254K.
  • Virtu Financial first reported a position in PTC Therapeutics in Q4 2017 and held it in 6 quarters.
  • Virtu Financial's PTC Therapeutics position peaked at $510K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.